These factors were age, tumor stage, cancer type, cerebrovascular disease, hypertension, personal history of VTE, and prechemotherapy laboratory variables, including blood leucocyte count, MPV, PDW, albumin concentration, LDH concentration, D-dimer concentration, fibrinogen concentration, blood hemoglobin concentration ≤ 100 g/dL or use of erythropoiesis-stimulating agents. This evidence concerns the gene ALB and neoplasm.